We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

39 hedge funds and large institutions have $15.3M invested in Filana Therapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more capital invested

Capital invested by funds: $10.9M → $15.3M (+$4.36M)

0.63% less ownership

Funds ownership: 5.93% → 5.3% (-0.63%)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

15% less funds holding

Funds holding: 46 → 39 (-7)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $21K

Holders
39
Holders Change
-7
Holders Change %
-15.22%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
8
Closed
8
Calls
–
Puts
$21K
Net Calls
-$21K
Net Calls Change
-$25K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$985K
2
ARTA
A.R.T. Advisors
New York
+$52K
3
Citadel Advisors
Citadel Advisors
Florida
+$17.3K
4
TSS
Two Sigma Securities
New York
+$17.3K
5
TU
TDAM USA
Ontario, Canada
+$15.3K

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$648K
2
AFM
Anson Funds Management
Texas
-$262K
3
Renaissance Technologies
Renaissance Technologies
New York
-$125K
4
ZIM
Zacks Investment Management
Illinois
-$117K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$77.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
TU
26
TDAM USA
Ontario, Canada
$21K +$15.3K +3,370 New
PAM
27
Panagora Asset Management
Massachusetts
$19K +$14K +3,090 New
Group One Trading
28
Group One Trading
Illinois
$16K – – –
Wells Fargo
29
Wells Fargo
California
$12K – – –
VKH
30
Virtu KCG Holdings
New York
$12K +$8.88K +1,957 New
FANJ
31
Financial Architects (New Jersey)
New Jersey
$4K – – –
Morgan Stanley
32
Morgan Stanley
New York
$4K – – –
Simplex Trading
33
Simplex Trading
Illinois
$4K +$3.17K +699 +699%
UBS Group
34
UBS Group
Switzerland
$1K -$53.9K -11,873 -99%
Federated Hermes
35
Federated Hermes
Pennsylvania
$1K – – –
AG
36
Advisor Group
Arizona
$1K +$1.04K +229 +1,090%
AFM
37
Anson Funds Management
Texas
– -$262K -65,667 Closed
ZIM
38
Zacks Investment Management
Illinois
– -$117K -29,387 Closed
6CM
39
683 Capital Management
New York
– -$29K -7,287 Closed
SIM
40
Spark Investment Management
New York
– -$23K -6,000 Closed
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
– -$19K -4,867 Closed
Brown Advisory
42
Brown Advisory
Maryland
– -$7K -1,686 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$5K -1,368 Closed
LTFS
44
Ladenburg Thalmann Financial Services
Florida
– -$1K -175 Closed
1
2

FLNA Hedge Fund Activity: Q1 2017 in Review

39 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2017, worth a combined $15.3M — up 40% from $10.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of FLNA and 5 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 7 added.

The largest buyer was BlackRock, opening a new position worth an estimated $985K. The largest seller was Nantahala Capital Management, cutting an estimated $648K.

  • 39 institutional investors held Filana Therapeutics (FLNA) as of Q1 2017, down from 46 in Q4 2016.
  • Funds reported $15.3M of Filana Therapeutics stock for Q1 2017, up 40% quarter-over-quarter.
  • 5 funds opened new Filana Therapeutics positions in Q1 2017 and 8 closed out, a net change of -3 holders.
  • The largest Filana Therapeutics buyer in Q1 2017 was BlackRock, an estimated $985K added.
  • The largest Filana Therapeutics seller in Q1 2017 was Nantahala Capital Management, an estimated $648K sold.

Based on aggregated 13F filings for Q1 2017.